Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Standard definitions and endpoints for neoadjuvant clinical trials in breast cancer |
| Full bibliographic reference | Fumagalli D, Bedard PL, Nahleh Z, Michiels S, Sotiriou C, Loi S, Sparano JA, Ellis M, Hylton N, Zujewski JA, Hudis C, Esserman L, Piccart M; BIG-NABCG collaboration. A common language in neoadjuvant breast cancer clinical trials: proposals for standard definitions and endpoints. Lancet Oncol. 2012;13(6):e240-248. |
| Language | English |
| PubMed ID | 22652232 |
| Study design | Clinical trials, Experimental studies |
| Clinical area | Oncology |
| Applies to the whole report or to individual sections of the report? | Terminology/definitions |
| Record last updated on | February 11, 2015 |